Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Tianyi Lu, PhD
Moderna, Inc.
Disclosure(s): Moderna, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1592) Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Associated Hospitalizations and Medically Attended COVID-19 among adults aged ≥ 18 years in the United States
Wednesday, October 22, 2025
12:15 PM - 1:30 PM
US ET
